Placebo response and remission rates in randomized trials of induction and maintenance therapy for ulcerative colitis
Jairath V., Zou GY., Parker CE., Macdonald JK., Alameel T., Al Beshir M., Almadi MA., Al-Taweel T., Atkinson NSS., Biswas S., Chapman T., Dulai PS., Glaire MA., Hoekman DR., Koutsoumpas A., Minas E., Mosli MH., Samaan M., Vandervoort MK., Travis S., D'Haens G., Levesque BG., Sandborn WJ., Feagan BG.
© 2015 The Cochrane Collaboration. This is the protocol for a review and there is no abstract. The objectives are as follows: The objective of this review is to identify the factors that contribute to placebo response and remission rates in induction and maintenance trials of UC in which patients with active or quiescent disease were enrolled using the UCDAI.